NE
Neogen Corporation
NEOG · NASDAQ
$11.83 +3.14% (+$0.36)
1M +4.69%
Market Cap $2.54B
P/E Ratio -
Div. Yield -
ROE 0.37%
Piotroski F-Score Moderate
6/9Valuation
34 /100
Fair P/S 2.92x
P/B 1.21x
P/FCF 79.57x
Growth
100 /100
Growing Book val. growth 32.65%
Rev. growth 19.28%
FCF growth N/A
Profitability
28 /100
Weak Net margin 0.91%
Op. margin 2.49%
FCF margin 3.67%
Quality
4 /100
Poor ROE 0.37%
ROA 0.24%
Asset turnover 0.26x
Debt
57 /100
Moderate Current ratio 3.82x
Int. coverage 0.85x
Net debt/EBITDA 3.53x
Stability
12 /100
Unstable Rev. volatility 30.70%
EPS volatility 6,600.82%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NEOG
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Mikhael Nassif
Employees
2,636
Headquarters
Lansing
Prihajajoči dogodki
08 OKT.
Earnings
Upcoming earnings report